Fundraising Fox

410 Medical

Durham, US · Delaware corporation · 7 known investors

410medical.com ↗

410 Medical makes LifeFlow, a hand-operated rapid infuser that lets clinicians quickly deliver blood or fluids to critically ill patients needing volume resuscitation. The device is aimed at hospital and emergency care settings for fluid resuscitation workflows.

HardwareHealthtechMedical Devices

Founders & leadership

MD
Mark Donald PiehlFounder
KC
KYLE CHENETExecutive

Board

JTJEFF TERRELL
JEFF TERRELLin𝕏Board Member2019–2025Partner at Arboretum Ventures
SD
STANLEY D. LYNALLBoard directorManaging Director, Venture Investments at OSF Ventures
FGFRED GOLDWATER
FRED GOLDWATERinBoard directorDigital Health Advisor at Excelerate Health Ventures
MT
MAYANK TANEJABoard directorVice President, Venture Investments at OSF Ventures
ML
Mike LiddellManager
LM
Lukas Miller RoushManager
BH
BOBBY HELMEDAGBoard director
DS
DANIEL S. DUFFYBoard director

Investors · 7

Ballad VenturesJohnson City · $500K – $1.5M
CU Healthcare Innovation FundAurora
Duke Capital PartnersDurham
OSF VenturesPeoria
Wolfpack Investor NetworkRaleigh · $250K – $5M
Bios PartnersreportedFort Worthvia Travis Whitfill · board
Hatteras Venture PartnersreportedResearch Triangle · $500K – $4M

Reported raises · per SEC filings

Form D private placements

$58.5M disclosed across 8 rounds · 2014–2026

▶$10.3MraisedJul 2026 · 11 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • KYLE CHENETExecutive Officer, Director
  • MARK DONALD PIEHLExecutive Officer, Director
  • BOBBY HELMEDAGDirector
  • FRED GOLDWATERDirector
  • DANIEL S. DUFFYDirector
  • MAYANK TANEJADirector
Offering amount
$12M
Amount sold
$10.3M
First sale
Jun 2026
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$25.7MraisedMar 2025 · 44 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • KYLE CHENETExecutive Officer, Director
  • BOBBY HELMEDAGDirector
  • JEFF TERRELLDirector
  • MARK DONALD PIEHLExecutive Officer, Director
  • STANLEY D. LYNALLDirector
  • DANIEL S. DUFFYDirector
Offering amount
$30.1M
Amount sold
$25.7M
First sale
Oct 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.1MraisedDec 2021 · 25 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • JEFF TERRELLDirector
  • MARK DONALD PIEHLExecutive Officer, Director
  • DANIEL S. DUFFYDirector
  • STANLEY D. LYNALLDirector
  • KYLE CHENETExecutive Officer, Director
  • LUKAS MILLER ROUSHDirector
Offering amount
$5M
Amount sold
$3.1M
First sale
Dec 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$7.6MraisedOct 2019 · 21 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • DANIEL S. DUFFYDirector
  • STANLEY D. LYNALLDirector
  • KYLE CHENETExecutive Officer, Director
  • MARK DONALD PIEHLExecutive Officer, Director
  • GALEN ROBERTSONExecutive Officer
  • LUKAS MILLER ROUSHDirector
  • JOHN R. TUSHARDirector
  • JEFF TERRELLDirector
Offering amount
$8M
Amount sold
$7.6M
First sale
Oct 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.1MraisedAug 2018 · 12 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • GALEN ROBERTSONExecutive Officer
  • DAN DUFFYDirector
  • MARK DONALD PIEHLExecutive Officer, Director
  • KYLE CHENETExecutive Officer, Director
  • TRAVIS WHITFILLDirector
  • JOHN R. TUSHARDirector
  • LUKAS MILLER ROUSHDirector
Offering amount
$4M
Amount sold
$3.1M
First sale
Aug 2018
Incorporated
Corporation, Delaware, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5.4MraisedJun 2017 · 35 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • KYLE CHENETExecutive Officer, Director
  • LARRY MILLERDirector
  • LUKAS MILLER ROUSHDirector
  • MARK DONALD PIEHLExecutive Officer, Director
  • TRAVIS WHITFILLDirector
  • GALEN ROBERTSONExecutive Officer
  • MIKE LIDDELLDirector
  • DAN DUFFYDirector
Offering amount
$6.5M
Amount sold
$5.4M
First sale
Mar 2017
Incorporated
Corporation, Delaware, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.2MraisedSep 2016 · 18 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Lukas RoushDirector
  • Mark PiehlExecutive Officer, Director
  • Galen RobertsonExecutive Officer
  • Mike LiddellDirector
Offering amount
$2.2M
Amount sold
$2.2M
First sale
Apr 2016
Incorporated
Limited Liability Company, North Carolina, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.1MraisedJan 2015 · 6 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Mike LiddellDirector
  • Mark Donald PiehlDirector
  • Lukas Miller RoushDirector
Offering amount
$1.1M
Amount sold
$1.1M
First sale
Dec 2014
Incorporated
Limited Liability Company, North Carolina, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 2

by search overlap
Medscape92 shared keywordsMedscape is an online medical information platform providing clinical news, expert perspectives, case studies, quizzes, and reference material across specialties such as cardiology, oncology, neurology, and psychiatry. It serves physicians, nurses, pharmacists, residents, and medical students.
Osmosis66 shared keywordsOsmosis is a US health education platform of short-form medical videos and learning tools, acquired by Elsevier.

Companies competing with 410 Medical for the same Google search keywords, organic and paid, via search-intersection analysis.

Non-dilutive funding · 6 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
U.S. Air ForceAir ForcePhase I2023$74.9K
U.S. Air ForceAir ForcePhase II2022$749.9K
U.S. Air ForceAir ForcePhase II2022$746.8K
U.S. Air ForceAir ForcePhase I2022$50K
U.S. Air ForceAir ForcePhase I2022$50K
U.S. Air ForceAir ForcePhase I2021$50K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does 410 Medical do?
410 Medical makes LifeFlow, a hand-operated rapid infuser that lets clinicians quickly deliver blood or fluids to critically ill patients needing volume resuscitation. The device is aimed at hospital and emergency care settings for fluid resuscitation workflows.
Who founded 410 Medical?
410 Medical was founded by Mark Donald Piehl.
Who are 410 Medical's investors?
410 Medical's investors include Ballad Ventures, CU Healthcare Innovation Fund, Duke Capital Partners, OSF Ventures, Wolfpack Investor Network, Bios Partners, Hatteras Venture Partners.
How much funding has 410 Medical raised?
410 Medical has disclosed $58.5M raised across 8 rounds.
Where is 410 Medical headquartered?
410 Medical is headquartered in Durham, US.